Hims & Hers Health, Inc. (HIMS) vs DENTSPLY SIRONA Inc. (XRAY)

HIMS leads on 6 of 11 compared metrics.

A side-by-side comparison of Hims & Hers Health, Inc. and DENTSPLY SIRONA Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — HIMS vs XRAY

growth of $100 · last 7y
HIMS +173.7%XRAY -80.4%HIMS compounded faster
Log scale — wide-divergence pair
101001kStart $100202120232025$274$20
HIMS XRAY

HIMS vs XRAY: by the numbers

  • HIMS is the larger company ($5.98B vs $2.02B market cap).
  • Both run net losses; HIMS's is the smaller (-0.56% vs -17.06% net margin).
  • HIMS grew revenue faster over the past five years (69.19% vs 1.12% CAGR).
  • XRAY pays a dividend (4.76% yield) while HIMS does not currently pay one.

Which is better, HIMS or XRAY?

Metric tally: HIMS 6 · XRAY 5

It depends on what you're optimizing for:

GrowthHIMS(faster 5Y revenue CAGR)
QualityHIMS(higher ROIC)

Valuation

MetricHIMSXRAY
Forward P/E56.937.11
P/S ratio2.580.55
P/B ratio13.731.53
EV / EBITDA234.03
FCF yield1.24%5.16%

Profitability

MetricHIMSXRAY
Gross margin67.64%48.93%
Operating margin1.32%5.87%
Net margin-0.56%-17.06%
ROE-2.97%-47.65%
ROIC6.02%5.67%

Dividends

MetricHIMSXRAY
Dividend yield4.76%

Growth (annualized)

MetricHIMSXRAY
Revenue CAGR (5Y)69.19%1.12%
EPS CAGR (5Y)-0.93%
FCF CAGR (5Y)-29.96%
Total return CAGR (5Y)17.04%-29.72%

Frequently asked

Which is better, HIMS or XRAY?
It depends on your goal. growth: HIMS (faster 5Y revenue CAGR); quality: HIMS (higher ROIC). Across all compared metrics, HIMS leads 6 to 5.
Which has grown faster, HIMS or XRAY?
Over the past five years, HIMS grew revenue faster — HIMS at a 69.19% CAGR versus XRAY at 1.12%.
Does HIMS or XRAY pay a bigger dividend?
XRAY pays a dividend (4.76% yield) while HIMS does not currently pay one.
Which has been the better investment, HIMS or XRAY?
Over the past 5-year, HIMS delivered the higher annualized total return — HIMS at 17.04% versus XRAY at -15.61%. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.